Back

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Innovations in public health and health economics (1) Public Health ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speakers

Photo
Mr Anders Holt

Herlev and Gentofte Hospital, Copenhagen (Denmark)

Photo
Miss Jingyuan Liang

Auckland (New Zealand)

4 More presentations in this session

Presentation thumbnail
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.
Professor A. Goette (Paderborn, DE)
Abstract Slides Video
Presentation thumbnail
Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography
Doctor J. Chung (Goyang, KR)
Abstract Slides Video
Presentation thumbnail
Quantity and quality of shared decision making incorporation across major international cardiology guidelines
Doctor B. MacDonald (Vancouver, CA)
Abstract Slides Video
Presentation thumbnail
Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries
Doctor M. Walli-Attaei (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Innovations in public health and health economics (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
thumbnail
Congress Presentation
The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia
thumbnail
Congress Presentation
EHRs and Omics for disease phenotypin

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources